£182.99

Monoamine Oxidase Inhibitors: Clinical Pharmacology, Benefits, & Potential Health Risks

Other Branches of Medicine

Price data last checked 74 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 17 days • 17 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 17 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £172 (15 days, 88.2%)

Price range: £172 - £183

Price levels: 2 different prices over 17 days

Description

This book provides basic and applied knowledge about monoamine oxidase inhibitors (MAOIs), their classification, and clinical application as neuroprotective agents and will be a valuable source of new knowledge for doctors, patients, medical students, teachers, researchers, and basic biomedical scientists interested in learning the appropriate clinical application of MAOIs without any misunderstanding for the prevention and/or treatment of neurological and neuropsychiatric disorders. The book will be of immediate interest to patients suffering from Parkinson's disease (PD), Alzheimer's disease (AD), post-traumatic stress disorders (PTSD), panic disorders, attention deficit hyperactivity disorders (ADHD), and major depression. Physicians interested in learning more about MAOIs and their molecular and pharmacological mechanism of action will highly benefit from the book's clinically-interesting contents. In general, this book will be a valuable source of knowledge for the basic researcher, clinically useful for the physician, and therapeutically-beneficial for the patients. The book can also serve as a guide for Masters and Ph.D students interested in conducting research on MAOIs. Particularly, MD doctors, students, and professors will find this book interesting to enhance their basic knowledge about MAOIs and their potential benefits and adverse effects for the better clinical management of drug-resistant PD, AD, and MDDs. Furthermore, recent knowledge regarding the molecular mechanism of MAOIs-mediated protection at the cellular, molecular, and genetic level is thought-provoking and motivates the young scientists to augment research on developing novel drugs with minimum or no adverse effects. It is envisaged that future research on specific CB-targeted MAOIs will have superior pharmacogenomics profiles, enhanced margin of safety, maximum therapeutic index, and minimum or no adverse effects.'

Product Specifications

Format: Hardcover
ASIN: 1634836006
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Other Branches of Medicine
Domain: Amazon UK
Release Date: 01 January 2016
Listed Since: 15 October 2015

Barcode

No barcode data available

Monoamine Oxidase Inhibitors: Clinical Pharmacology, Benefits, & Potential Health Risks

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors

Psychiatric and Mood Diseases and the Natural Compounds: An Approach to the Future Medical Tool (Psychiatry - Theory, Applications and Treatments)

The Pharmacological Guide to Paroxetine (Pharmacology - Research, Safety Testing and Regulation)

Neurochemistry: Molecular and Cellular Clinical Applications

Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents

Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents

Attention-Deficit/Hyperactivity Disorder and the Hyperkinetic Syndrome: Current Ideas and Ways Forward

The Adenosinergic System: A Non-Dopaminergic Target in Parkinson’s Disease: 10 (Current Topics in Neurotoxicity)

Neuroscience for Psychologists and Other Mental Health Professionals: Promoting Well-Being and Treating Mental Illness

Cognition and Mood Interactions

Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders

Psychopharmacology of Neurologic Disease: Handbook of Clinical Neurology Series (Volume 165)

Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations

Major Depressive Disorder: Risk Factors, Characteristics & Treatment Options (Psychiatry - Theory, Applications and Treatments)

Biogenic Amines: Pharmacological, Neurochemical and Molecular Aspects in the CNS (Pharmacology - Research, Safety Testing and Regulation)

Managing Treatment-Resistant Depression: Road to Novel Therapeutics

American Psychiatric Publishing Textbook of Neuropsychiatry

Springer - Ketamine: From Abused Drug to Rapid-Acting Antidepressant

Global Emergency of Mental Disorders

Adenosine Receptors in Neurodegenerative Diseases

Calcium Ion Modulators: The New Wave of Pschotropic Drugs

New Rapid-acting Antidepressants (Contemporary Clinical Neuroscience)

Psychiatric Drugs in Children and Adolescents: Basic Pharmacology and Practical Applications

Neuropsychiatric Symptoms of Movement Disorders (Neuropsychiatric Symptoms of Neurological Disease)